期刊
PATIENT PREFERENCE AND ADHERENCE
卷 9, 期 -, 页码 759-765出版社
DOVE MEDICAL PRESS LTD
DOI: 10.2147/PPA.S81509
关键词
cord blood transplantation; mesenchymal stem cell; aplastic anemia
资金
- National Natural Science Foundation of People's Republic of China [81170492, 81370673]
- National High Technology Research and Development Program 863 of People's Republic of China [2012AA022703]
- National Key Basic Research Program 973 of People's Republic of China [2010CB732404]
- Key Medical Projects of Jiangsu Province [BL2014078]
- Key Discipline of Jiangsu Province
Delayed hematopoietic recovery and increased rate of engraftment failure limit the use of umbilical cord blood transplantation (UCBT). We describe a case of severe aplastic anemia treated by UCBT combined with mesenchymal stem cells. Our case reveals that infusing mesenchymal stem cells early (about 40 days) after UCBT may promote hematopoietic recovery. This experience will guide clinical scientists, especially hematologists, to deal with similar situations and encourage them to widen this strategy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据